Cargando…

The pseudogene PRELID1P6 promotes glioma progression via the hnHNPH1-Akt/mTOR axis

Research over the past decade has suggested important roles for pseudogenes in glioma. This study aimed to show that pseudogene PRELI domain-containing 1 pseudogene 6 (PRELID1P6) promotes glioma progression. Aberrant expression of genes was screened using The Cancer Genome Atlas database. We found t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xi, Shaoyan, Cai, Haiping, Lu, Jiabin, Zhang, Yu, Yu, Yanjiao, Chen, Furong, Huang, Qitao, Wang, Fang, Chen, Zhongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249232/ https://www.ncbi.nlm.nih.gov/pubmed/34108621 http://dx.doi.org/10.1038/s41388-021-01854-x

Ejemplares similares

LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis
por: Cai, Haiping, et al.
Publicado: (2020)

TgPRELID, a Mitochondrial Protein Linked to Multidrug Resistance in the Parasite Toxoplasma gondii
por: Jeffers, Victoria, et al.
Publicado: (2017)

UPF1 impacts on mTOR signaling pathway and autophagy in endometrioid endometrial carcinoma
por: Zhang, Minfen, et al.
Publicado: (2021)

STIM1 controls calcineurin/Akt/mTOR/NFATC2-mediated osteoclastogenesis induced by RANKL/M-CSF
por: Huang, Yanjiao, et al.
Publicado: (2020)

AAA + ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1
por: Umanah, George K. E., et al.
Publicado: (2022)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Circular RNA ZBTB46 depletion alleviates the progression of Atherosclerosis by regulating the ubiquitination and degradation of hnRNPA2B1 via the AKT/mTOR pathway
por: Fu, Yahong, et al.
Publicado: (2023)

HMGA1-pseudogenes and cancer
por: De Martino, Marco, et al.
Publicado: (2016)

α-Enolase Lies Downstream of mTOR/HIF1α and Promotes Thyroid Carcinoma Progression by Regulating CST1
por: Liu, Yang, et al.
Publicado: (2021)

Allicin promotes autophagy and ferroptosis in esophageal squamous cell carcinoma by activating AMPK/mTOR signaling
por: Guo, Zhanfang, et al.
Publicado: (2022)

Pseudogene KRT17P3 drives cisplatin resistance of human NSCLC cells by modulating miR‐497‐5p/mTOR
por: Hou, Zhibo, et al.
Publicado: (2020)

IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma
por: Folgiero, Valentina, et al.
Publicado: (2016)

Pseudogenes
por: Tutar, Yusuf
Publicado: (2012)

hnRNPM guides an alternative splicing program in response to inhibition of the PI3K/AKT/mTOR pathway in Ewing sarcoma cells
por: Passacantilli, Ilaria, et al.
Publicado: (2017)

Interaction between NBS1 and the mTOR/Rictor/SIN1 Complex through Specific Domains
por: Wang, Jian-Qiu, et al.
Publicado: (2013)

Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer
por: Cao, Guo-dong, et al.
Publicado: (2016)

mTOR, AMBRA1, and autophagy: An intricate relationship
por: Nazio, Francesca, et al.
Publicado: (2013)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

Pseudogenes in Cardiovascular Disease
por: Qi, Yanyan, et al.
Publicado: (2021)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Human VDAC pseudogenes: an emerging role for VDAC1P8 pseudogene in acute myeloid leukemia
por: Pappalardo, Xena Giada, et al.
Publicado: (2023)

Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors
por: Hassan, Burhan, et al.
Publicado: (2014)

Deletion of PTENP1 pseudogene in human melanoma
por: Poliseno, Laura, et al.
Publicado: (2011)

Differentially-Expressed Pseudogenes in HIV-1 Infection
por: Gupta, Aditi, et al.
Publicado: (2015)

FTH1 Pseudogenes in Cancer and Cell Metabolism
por: Di Sanzo, Maddalena, et al.
Publicado: (2020)

Evolution and function of developmentally dynamic pseudogenes in mammals
por: Qian, Sheng Hu, et al.
Publicado: (2022)

Role of mTOR Signaling in Female Reproduction
por: Guo, Zaixin, et al.
Publicado: (2019)

Akt1 Enhances CA916798 Expression through mTOR Pathway
por: Wang, Yu-Liang, et al.
Publicado: (2013)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017)

Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor
por: Rodrik-Outmezguine, Vanessa S., et al.
Publicado: (2016)

Regulation of the mTOR-Rac1 axis in platelet function
por: Aslan, Joseph E., et al.
Publicado: (2012)

Dysregulation of mTOR activity through LKB1 inactivation
por: Zhou, Wei, et al.
Publicado: (2013)

YB-1 Synthesis Is Regulated by mTOR Signaling Pathway
por: Lyabin, Dmitry N., et al.
Publicado: (2012)

Elucidating the role of Lkb1 and mTOR in adipose tissue
por: Xu, Ziye, et al.
Publicado: (2018)

Pharmacologic activation of autophagy without direct mTOR inhibition as a therapeutic strategy for treating dry macular degeneration
por: Zhang, Qitao, et al.
Publicado: (2021)

mTOR signaling in skeletal development and disease
por: Chen, Jianquan, et al.
Publicado: (2018)

mTOR and lysosome regulation
por: Puertollano, Rosa
Publicado: (2014)

mTOR, autophagy, and reprogramming
por: Tang, Bor Luen
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v1m8cqofdstpld7a4a6e3mob3s